PDCD1 and neoplasm: Inspired by the similarity of gut microbiota and tumor-derived antigens, a therapeutic vaccine has been developed using “oncomimic” peptides in conjunction with anti-PD-1 for treatment of colorectal cancer (Identifier: NCT05350501).